Showing 6641-6650 of 21443 results for "".
- Birth Outcomes: Evaluating Antiviral Therapy for COVID-19 in Pregnancyhttps://reachmd.com/news/birth-outcomes-evaluating-anti-viral-therapy-for-covid-19-in-pregnancy/2474331/The COVID-19 pandemic has required rapid recalibration of treatment protocols for vulnerable populations, particularly pregnant women. Emerging research suggests that antiviral therapy may influence key birth outcomes, such as gestational age at delivery and neonat
- Loneliness Assessment: Evaluating Consistent Emotional and Cognitive Patternshttps://reachmd.com/news/loneliness-assessment-evaluating-consistent-emotional-and-cognitive-patterns/2474401/Despite the varied ways clinicians attempt to measure loneliness—be it how often a person feels isolated, how much distress it causes, or how long it lasts—new research suggests that the emotional and cognitive roots of the experience remain remarkably consistent.
- Study Shows Prognostic Value of 40-GEP in Advanced cSCChttps://reachmd.com/news/study-shows-prognostic-value-of-40-gep-in-advanced-cscc/2474383/A new multi-institutional study indicates that a 40-gene expression profile (40-GEP) test with traditional staging enhances risk stratification for cutaneous squamous cell carcinoma (cSCC), even among patients already categorized as high- or very-high-risk using Na
- Radioligand Therapy and Patient Advocacy in Neuroendocrine Tumourshttps://reachmd.com/news/radioligand-therapy-and-patient-advocacy-in-neuroendocrine-tumours/2474353/Amidst the evolving frontier of cancer treatment, a promising alliance is reshaping outcomes for patients with neuroendocrine tumours: the union of targeted radioligand therapy and robust patient advocacy. As clinical innovations offer new hope, organized patient e
- Machine Learning: Assessing Cardiovascular Risk and Bone Healthhttps://reachmd.com/news/machine-learning-assessing-cardiovascular-risk-and-bone-health/2474365/Advances in machine learning have yielded a novel algorithm that evaluates routine bone density scans to identify cardiovascular incidents and fall-related fractures early. Preliminary findings from academic research highlight this technology's potential to revolutionize cl
- Bridging the Gap: Enhancing Cancer Screening in Marginalized Communitieshttps://reachmd.com/news/cancer-screening-implementation-barriers-and-enablers-in-primary-care-for-marginalized-populations/2474357/Effective cancer screening in primary care remains one of the most powerful tools for early detection and intervention. Yet for marginalized communities, significant obstacles persist—limiting access to life-saving services and exacerbating health disparities. Draw
- RILECSU Study: Rilzabrutinib Effective for Symptoms in Hard-to-Treat Urticariahttps://reachmd.com/news/rilecsu-trial-rilzabrutinib-eases-symptoms-in-hard-to-treat-urticaria/2474350/Rilzabrutinib significantly reduced itch and hives in adults with antihistamine-refractory chronic spontaneous urticaria (CSU), according to new phase 2 trial results published in JAMA Dermatology.
- Stroke Prevention: Reevaluating Strategies for Mild Carotid Narrowinghttps://reachmd.com/news/stroke-prevention-reevaluating-strategies-for-mild-carotid-narrowing/2474323/New research is compelling healthcare professionals to rethink one of the foundational assumptions in stroke prevention: that only severe carotid artery blockages significantly elevate ischemic stroke ri
- Environmental Chemicals and Female Fertility: The Role of DEHP Exposurehttps://reachmd.com/news/environmental-chemicals-and-female-fertility-the-role-of-dehp-exposure/2474379/Groundbreaking research from the Karolinska Institutet confirms that even minimal doses of the plasticizer DEHP threaten hormonal equilibrium, with significant repercussions for female fertility. Professionals in OB/GYN and Women’s Health are in
- Bausch Health Launches Fraxel FTX™ at ASLMS 2025https://reachmd.com/news/bausch-health-launches-fraxel-ftx-at-aslms-2025/2475353/Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a natio